**Executive Summary**
The document is a response to an unstarred question in Lok Sabha regarding the Revamped Pharmaceutical Technology Upgradation Assistance (RPTUA) Scheme. It provides details on the scheme's launch in March 2024, its financial outlay of ₹300.10 crore for F.Y. 2024-2025 to 2025-2026, and incentives offered to pharmaceutical companies based on their turnover to encourage technology upgrades. It also lists the 255 pharmaceutical companies that have been sanctioned under the RPTUA scheme.
**Key Points / Main Content**
* **RPTUA Scheme Overview**
* Launched in March 2024 to facilitate technology upgrades in pharmaceutical units.
* Aims to comply with Revised Schedule-M and WHO-GMP quality standards.
* Financial outlay of ₹300.10 crore from F.Y. 2024-2025 to 2025-2026.
* **Incentive Structure**
* Pharmaceutical units are eligible for incentives ranging from 10% to 20%, up to a maximum of ₹2.00 crore.
* Incentives are based on the average turnover during the last three years:
* ₹1 crore to ₹50 crore: 20% investment incentive
* ₹50 crore to ₹250 crore: 15% investment incentive
* ₹250 crore to ₹500 crore: 10% investment incentive
* **Sanctioned Projects and Disbursement**
* 255 pharmaceutical companies have been sanctioned grants-in-aid totaling ₹248.20 crore.
* Five units in Tamil Nadu received a grant-in-aid of ₹5.92 crore.
* Financial assistance is released upon certification of compliance with Schedule M and WHO-GMP by the drug regulatory authority.
* Out of 255 approved companies, ₹18.25 crore of incentives has been disbursed to 19 companies as of 31.1.2026.
* **Government Initiatives for Private Sector Encouragement**
* Production Linked Incentive (PLI) Schemes are implemented to encourage the establishment of more pharma companies.
* PLI Scheme for Bulk Drugs: Aims to reduce supply disruption risk with a total budgetary outlay of ₹6,940 crore.
* PLI Scheme for Pharmaceuticals: Aims to enhance India's manufacturing capabilities with a total budgetary outlay of ₹15,000 crore.
* **List of Pharmaceutical Companies:** The document provides a detailed list of 255 pharmaceutical companies state-wise along with the year of sanction under the RPTUA Scheme
**Impact Analysis**
**Pharmaceutical Companies**
* **Impact:** Opportunity to upgrade technology, comply with quality standards (Revised Schedule-M and WHO-GMP), and receive financial incentives.
* **Action Required:** Assess eligibility, apply for RPTUA Scheme, implement technology upgrades, and seek certification from the drug regulatory authority.
**Drug Regulatory Authority**
* **Impact:** Responsible for verifying compliance with Revised Schedule-M and WHO-GMP standards.
* **Action Required:** Certify compliance to facilitate the release of financial assistance to pharmaceutical companies.
**Citizens / Patients**
* **Impact:** Increased availability of quality medicines and pharmaceutical drugs through private sector establishment of more pharma companies.
* **Action Required:** No action required
Key Entities Referenced
Revamped Pharmaceutical Technology Upgradation Assistance (RPTUA) Scheme: A scheme launched by the Department of Pharmaceuticals to facilitate technology upgradation of existing pharmaceutical units to comply with quality standards, including the revised Schedule-M and WHO-GMP.
Department of Pharmaceuticals: The department within the Ministry of Chemicals and Fertilizers responsible for formulating policies, schemes, and programs related to the pharmaceutical sector in India, including the RPTUA Scheme and PLI schemes.
Production Linked Incentive (PLI) Scheme for Pharmaceuticals: A scheme that aims to enhance India's manufacturing capabilities by increasing investment and production of high-value goods in the pharmaceutical sector.
Production Linked Incentive (PLI) Scheme for Bulk Drugs: A scheme for promotion of domestic manufacturing of critical Key Starting Materials, Drug Intermediates and Active Pharmaceutical Ingredients.
Tamil Nadu: A state in India with specific mentions regarding benefit and allocation under RPTUA Scheme
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
DEPARTMENT OF PHARMACEUTICALS
LOK SABHA
UNSTARRED QUESTION No. 1327
TO BE ANSWERED ON 6th FEBRUARY, 2026
Revamped RPTUA Scheme
1327. Thiru D M KathirAnand:
Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:
(a) whether the Government has launched the Revamped Pharmaceutical Technology
Upgradation Assistance (RPTUA) Scheme for small and medium pharmaceutical companies in
the country, if so, details thereof;
(b) the list of pharmaceutical established and benefited from RPTUA Scheme since its inception,
State and year-wise especially in Tamil Nadu;
(c) the total amount allocated, disbursed and utilized for the implementation of the RPTUA
Scheme, year and State-wise especially in Tamil Nadu;
(d) whether the Government is keen on encouraging private sector for the establishment of more
pharma companies to tackle severe shortage of medicines and pharmaceutical drugs, if so, the
details thereof and action taken in this regard?
ANSWER
THE MINISTER IN THE MINISTRY OF CHEMICALS AND FERTILIZERS
(SHRI JAGAT PRAKASH NADDA)
(a): Yes. Department of Pharmaceuticals launched Revised Pharmaceutical Technology
Upgradation Assistance Scheme (RPTUAS) in March, 2024 with a view to facilitate technology
upgradation of existing pharmaceutical units to comply with Revised Schedule-M and World
Health Organization - Good Manufacturing Practices (WHO-GMP) quality standards. The
financial outlay of the scheme is ₹300.10 crore from F.Y. 2024-2025 to 2025-2026.
Under RPTUAS, Pharmaceutical units are eligible to receive incentive ranging from 10%
to 20% subject to a maximum of ₹ 2.00 crore based on their average turnover during the last
three years as per the following categories:
S. No. Turnover Incentive as % of investment
1. ₹ 1 crore to ₹ 50 crore 20%
2. ₹ 50 crore to ₹ 250 crore 15%
3. ₹ 250 crore to ₹ 500 crore 10%
(b) and (c): Projects sanctioned so far involve grant-in-aid to 255 pharmaceutical companies for
a total amount of ₹ 248.20 crore, including five units with grant-in-aid for a total amount of ₹
5.92 crore in the State of Tamil Nadu. Release and utilisation of financial assistance under the
scheme is to be done on receipt of certification by the drug regulatory authority concerned
regarding compliance with the revised Schedule M to the Drugs Rules, 1945 and the World
Health Organization – Good Manufacturing Practices. List of 255 pharmaceutical companies
state and year wise approved under the RPTUAS is at Annexure-I.As on 31.1.2026, out of 255 approved pharmaceutical companies, the Scheme Steering
Committee in its meeting held on 23.12.2025 has approved the disbursement of incentives
amount to the tune of ₹ 18.25 crore to 19 pharmaceutical companies.
(d) Yes Sir, the Production Linked Incentive (PLI) schemes implemented by the Department of
Pharmaceuticals has encouraged private sector for the establishment of more pharma companies
to manufacture medicines and pharmaceutical drugs. Scheme-wise details are as under:
(i) PLI Scheme for promotion of domestic manufacturing of critical KSMs/DIs/APIs in
India (commonly known as the PLI Scheme for Bulk Drugs): The scheme, which has a total
budgetary outlay of ₹6,940 crore, aims to avoid disruption in supply of critical active
pharmaceutical ingredients (APIs) used to make critical drugs for which there are no
alternatives by reducing supply disruption risk due to excessive dependence on single source.
The scheme provides financial incentives on the sale of 41 identified KSMs/ DIs/ APIs
products manufactured through greenfield projects set up under the scheme. Under the
scheme, 48 projects are approved for manufacturing of 33 bulk drugs.
(ii) PLI Scheme for Pharmaceuticals: The scheme, which has a total budgetary outlay of
₹15,000 crore, aims to enhance India’s manufacturing capabilities by increasing investment
and production in the sector and contributing to product diversification to high-value goods
in the pharmaceutical sector. It incentivises production of high-value medicines such as
biopharmaceuticals, complex generic drugs, patented drugs or drugs nearing patent expiry,
auto-immune drugs, anti-cancer drugs, etc. as well as production of KSMs/ DIs/ APIs other
than those notified under the PLI Scheme for Bulk Drugs, thereby contributing to self-
reliance. Under the scheme, 55 applicants are approved for manufacturing of pharmaceuticals
and in-vitro medical devices (IVDs) manufactured through both greenfield and brownfield
projects.Annexure-I
Annexure referred to in reply to part (b) of the LOK SABHA UNSTARRED Q. NO. 1327
for answer on 06.02.2026, raised by Shri Thiru D M KathirAnand, regarding Revamped
RPTUA Scheme
List of pharmaceutical companies whose projects have been considered and sanctioned
under RPTUAS
State / Union Year of
Sr. No Applicant Pharmaceutical company
Territory sanction
1 Dinakara Life Science Pvt. Ltd.
2 Alapati Pharma 2024
3 Inchem Laboratories Pvt. Ltd.
Andhra
4 Alivira Animal Health Ltd.
Pradesh
5 Aparna Pharmaceuticals Pvt. Ltd.
2025
6 Sionc Pharmaceutical Pvt. Ltd.
7 Rathnam Pharmaceuticals
8 Assam Signova Healthcare Pvt. Ltd. Unit-II 2025
9 Bihar Ornate Labs Pvt. Ltd. 2024
10 Anuja Healthcare Ltd.
11 Chandigarh Saurav Chemicals Ltd. 2024
12 Torque Pharmaceuticals Pvt. Ltd.
Dadra and
Nagar Haveli
13 V S International Pvt. Ltd. 2025
and Daman and
Diu
14 Navil Laboratories Pvt. Ltd.
15 Bakul Pharma Pvt. Ltd.
16 Denis Chem Lab Ltd.
17 Sangharsh Lifecare Pvt. Ltd.
18 Virdev Intermediates Pvt. Ltd.
19 Bdr Lifesciences Pvt. Ltd.
20 Kentreck Laboratories Pvt. Ltd.
21 Vasa Pharmachem Pvt. Ltd.
22 Gujarat Neha Life Science Pvt. Ltd. 2024
23 Arnav Research Laboratories
24 Altis Finchem Pvt. Ltd.
25 Swati Chemicals
26 B. Sharda Pharma Pellets Pvt. Ltd.
27 Adrhim Pharmaceuticals LLP
28 Nucare Laboratories India
29 Shiva Healthcare
30 Exotic Pharma31 Shc Pharmaceuticals
32 Padmavati Chemicals Pvt. Ltd.
33 Yash Medicare Pvt. Ltd.
34 Avik Pharmaceutical Ltd.
35 Rajdip Pharmaceuticals
36 Trio Lifescience Pvt. Ltd.
37 Trio Remedies Pvt. Ltd.
38 Maruti Industries
39 Pulse Pharma Manu Co.
40 C P M Enterprise
41 Salus Pharmaceuticals
42 Sanket Healthcare
43 Sahajanand Life Sciences Pvt. Ltd.
44 Exemed Pharmaceuticals
45 Manish Pharma Lab
46 Sg Healthcare Pvt. Ltd.
47 Suchem Laboratories
48 Krozex Remedies Pvt. Ltd.
49 Shelat Brothers
50 Carewin Pharmaceuticals Gujarat Pvt. Ltd.
51 Luxica Pharma Inc.
52 Techno Drugs And Intermediates Pvt. Ltd.
53 Sbf Pharma Pvt. Ltd. 2025
54 Sruzam Labs Pvt. Ltd.
55 Shree Pharma (India)
56 Lexmark Pharmaceuticals Pvt. Ltd.
57 Hbc Healthcare Pvt. Ltd.
58 Lex-Mark Healthcare LLP
59 Seejar Pharmaceuticals
60 Parth Laboratories Pvt. Ltd.
61 Adani Pharmachem Pvt. Ltd.
62 Snj Labs Pvt. Ltd.
63 Vm Chemicals
64 Nira Life Sciences Pvt. Ltd.
65 Bdr Pharmaceuticals International Pvt. Ltd.
66 Nebula Healthcare Ltd.
67 Ethicare Pharmaceuticals Pvt. Ltd.
68 Divine Life Care Pvt. Ltd.
69 Dwarkesh Healthcare
70 Sunij Pharma Pvt. Ltd.
71 Modi Antibiotics72 Sprout Laboratories Pvt. Ltd.
73 Indamed Pharmaceuticals Pvt. Ltd.
74 Sehat Pharma Pvt. Ltd.
75 Intracin Pharmaceuticals Pvt. Ltd.
Navin Saxsena Research And Technology
76
Pvt. Ltd.
77 Vadish Pharma Pvt. Ltd.
78 Apex Formulations Pvt. Ltd.
79 Omega Pharmaceuticals
80 Bharat Parenterals Ltd.
81 Oneiro Lifecare Pvt. Ltd.
82 Protech Biosystem Pvt. Ltd.
2024
83 Mcneil And Argus Pharmaceuticals Ltd.
84 Haryana Mitra Industries Pvt. Ltd.
85 Astonea Labs Ltd. 2025
86 Sia Pharma Pvt. Ltd.
87 M Sea Pharmaceuticals Pvt. Ltd.
88 Three B Healthcare Ltd.
89 Pharma Force Lab
90 Park Pharmaceuticals
91 Ethix Health Care
92 Bennet Pharmaceuticals Ltd.
93 Maxwell Pharma
94 Auraya Healthcare Unit-II
95 Medoz Pharmaceuticals Pvt. Ltd.
96 Unispeed Pharmaceuticals Pvt. Ltd.
97 Sirmour Remedies Pvt. Ltd.
98 Mediforce Healthcare Pvt. Ltd.
Himachal
99 Goish Remedies Ltd. 2024
Pradesh
100 Alexi Pharmicia Pvt. Ltd.
101 Brit Lifescience
102 Biodeal Pharmaceuticals Ltd.
103 Next Wave India
104 Varav Biogenesis Pvt. Ltd.
105 Gnosis Pharmaceuticals Pvt. Ltd.
106 Higgs Healthcare
107 Unix Biotech
108 Algen Healthcare Ltd.
109 Nixi Laboratories Pvt. Ltd.
110 Medicef Pharma
111 Osper Formulation Pvt. Ltd.112 Brd Medilabs
113 Legen Healthcare
114 Caspian Pharmaceuticals
115 Saphnix Life Sciences
116 Healkraft Pharma (India) Pvt. Ltd.
117 Dm Pharma Pvt. Ltd.
118 Athens Life Sciences
119 Purobien Lifesciences
120 Smayan Healthcare Pvt. Ltd.
121 Soft Touch Pharmaceuticals Pvt. Ltd.
122 Magbro Health Care Pvt. Ltd.
123 Brooks Laboratories Ltd.
124 Syskem Pharmocrats
125 Auraya Healthcare
126 Lifecare Neuro Products Ltd.
127 Hanuchem Laboratories Unit III
128 Himsagar Laboratories Ltd.
129 Mmg Healthcare
2025
130 Vellinton Healthcare
131 Nanz Med Science Pharma Pvt. Ltd.
132 Sarv Bio Labs Pvt. Ltd.
133 Medisys Biotech Pvt. Ltd.
134 Grampus Laboratories
135 Legency Remedies Pvt. Ltd.
136 Sunlife Pharma Services
137 Pinnacle Life Science Pvt. Ltd.
138 Martin & Brown Bio Sciences Pvt. Ltd.
139 Pacific India
140 Kantil Pharmaceuticals Pvt. Ltd.
141 Ekanthika Pharmaceuticals
142 Ramom Health Care Pvt. Ltd.
143 Vrindaan Global
144 Curetech Skincare
145 Maxtar Bio Genics
146 Jammu & Vowcare Products 2024
147 Kashmir Protech Biopharma Pvt. Ltd. 2025
148 Ce Chem Pharmaceuticals Pvt. Ltd.
149 Nandu Chemical Industries 2024
150 Karnataka Recipharm Pharmaservices Pvt. Ltd.
151 Kemwell Biopharma Pvt. Ltd.
2025
152 Anglo-French Drugs & Industries Ltd.153 Nandu Chemicals Pvt. Ltd.
154 M N Chemicals Ltd.
155 Natural Capsules Ltd.
156 Adeep Life Sciences Pvt. Ltd.
157 Vazrachem Specialities
158 Chethana Formulations Pvt. Ltd.
159 Kerala Lab induss Ltd. 2025
160 Megasys Biotek Pvt. Ltd.
161 Zenith Drugs Ltd.
2024
162 Schon Pharmaceuticals Ltd.
163 Modern Laboratories
164 Beryl Drugs Ltd.
165 Madhya Nandani Medical Laboratories Pvt. Ltd.
166 Pradesh Hind Pharma
2025
167 Garima Healthcare Pvt. Ltd.
168 Riemann Labs Pvt. Ltd.
169 Cipco Ltd.
170 Arc Pharmaceuticals
171 Scitech Specialities Pvt. Ltd.
172 Murli Krishna Pharma Pvt. Ltd.
173 Emil Pharmaceutical Industries Pvt. Ltd.
174 Aqua Fine Injecta Pvt. Ltd.
175 Srikem Laboratories Pvt. Ltd.
176 Sunshine Organics Pvt. Ltd.
177 Aveo Pharmaceuticals Pvt. Ltd. 2024
178 Embio Ltd.
179 Nitika Pharmaceutical Specialities Pvt. Ltd.
180 Hindustan Antibiotics Ltd.
181 Sequent Scientific Ltd.
182 Maharashtra Kores (India) Ltd.
183 Great Pacific Export Pvt. Ltd.
184 Anek Prayog Pvt. Ltd.
185 Vav Lipids Pvt. Ltd.
186 Leben Laboratories Pvt. Ltd.
187 Arco Life Science (India) Pvt. Ltd.
188 Oceanic Laboratories Pvt. Ltd.
2025
189 Surajlok Chemicals Pvt. Ltd.
190 Korten Pharmaceuticals Pvt. Ltd.
191 Eisen Pharmaceutical Co Pvt. Ltd.
192 Sydler Remedies Pvt. Ltd.
193 Anant Pharmaceuticals Pvt. Ltd.Unilab Chemicals And Pharmaceuticals Pvt.
194
Ltd.
195 Zen Chemicals Pvt. Ltd.
196 Orex Pharma Pvt. Ltd.
197 U S Pharma (India) Pvt. Ltd.
198 Flamingo Pharmaceuticals Ltd.
199 Laxachem Organics Pvt. Ltd.
200 Sanpras Health Care Pvt. Ltd.
201 M J Biopharm Pvt. Ltd.
202 Bakul Aromatics And Chemicals Pvt. Ltd.
203 Nysa Biomed Pvt. Ltd.
204 Pell Tech Health Care Pvt. Ltd.
205 Asuwaldi Pharmaceuticals
M/S Jagannath Chemical And Pharmaceutical
206 Odisha 2025
Works Pvt. Ltd.
207 Velite Pharmaceuticals
2024
208 Punjab Systacare Remedies
209 Gag Pharmaceuticals 2025
210 Lark Laboratories India Ltd. 2024
211 Rajasthan D.D. Pharmaceuticals Pvt. Ltd.
2025
212 Kusum Healthcare Pvt. Ltd.
213 Life Care Formulations Pvt. Ltd.
Puducherry 2025
214 Linux Life Sciences Pvt. Ltd.
215 Saimirra Innopharm Pvt. Ltd. 2024
216 Tychos Therapeutics Pvt. Ltd.
217 Tamil Nadu Medibest Pharma Pvt. Ltd. 2024
218 Pharm Products Pvt. Ltd.
219 Bafna Pharmaceuticals Ltd. 2025
220 Sreepathi Pharmaceuticals Ltd.
221 Dano Vaccines & Biologicals Pvt. Ltd.
2024
222 Magnum Chemi Gran Pvt. Ltd.
223 Sanzyme Pvt. Ltd.
Telangana
224 Maithri Drugs Pvt. Ltd.
225 Rashmi Pharma Pvt. Ltd.
2025
226 Yeluri Formulations Pvt. Ltd.
227 Kekule Pharma Ltd.
228 Radicon Laboratories Ltd.
2024
229 Uttar Pradesh Daffodills Pharmaceuticals Ltd.
230 Indo Gulf Pharmaceuticals 2025
231 Daffohils Laboratories Pvt. Ltd.
Uttarakhand 2024
232 Pro-Pharma Care Pvt. Ltd.233 Sarv Pharmaceuticals
234 Talent Healthcare
235 Prochem Pharmaceuticals Pvt. Ltd.
236 Tosc International Pvt. Ltd.
237 Karnani Pharmaceuticals Pvt. Ltd.
238 Evolet Pharmaceuticals Pvt. Ltd.
239 Indian Drug Vision
240 Cotec Health Care Pvt. Ltd.
241 Aagya Biotech Pvt. Ltd.
242 Rusan Pharma Ltd.
243 Tulbros Formulations
244 Suncare Formulations Pvt. Ltd.
2025
Verve Human Care Laboratories A Unit Of
245
Venor Pharma Ltd.
246 Suraksha Pharma Pvt. Ltd.
Supermax Drugs And Pharmaceuticals Pvt.
247
Ltd.
248 Sushima Laboratories
249 Vulcan Laboratories Pvt. Ltd.
250 Mendine Pharmaceuticals Pvt. Ltd.
251 Diamond Drugs Pvt. Ltd. 2024
252 West Bengal Pharma Impex Laboratories Pvt. Ltd.
253 Gena Pharmaceuticals Ltd.
254 Hygeia Pharmaceuitcals Mfg Pvt. Ltd.
2025
255 Tetradrip Pharma Pvt. Ltd.
*******